Phase Ib study of adavosertib in combination with olaparib in patients with refractory solid tumors: Dose escalation Meeting Abstract


Authors: Hamilton, E.; Falchook, G. S.; Wang, J. S.; Fu, S.; Oza, A.; Karen, S.; Imedio, E. R.; Kumar, S.; Ottesen, L.; Mugundu, G. M.; Chmielecki, J.; Jones, S.; Spigel, D. R.; Li, B. T.
Abstract Title: Phase Ib study of adavosertib in combination with olaparib in patients with refractory solid tumors: Dose escalation
Meeting Title: 110th Annual Meeting of the American Association for Cancer Research (AACR)
Journal Title: Cancer Research
Volume: 79
Issue: 13 Suppl.
Meeting Dates: 2019 Mar 29-Apr 3
Meeting Location: Atlanta, GA
ISSN: 0008-5472
Publisher: American Association for Cancer Research  
Date Published: 2019-07-01
Language: English
ACCESSION: WOS:000488129900023
DOI: 10.1158/1538-7445.Am2019-ct025
PROVIDER: wos
Notes: Meeting Abstract: CT025 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Bob Tingkan Li
    278 Li